A third dose of Pfizer and BioNTech's coronavirus vaccine restored the shot's strong protection against COVID-19 in a large randomized trial, the companies said Thursday, offering the most substantial clinical evidence to date in support of booster shots.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,